Kymera Therapeutics Inc

NASDAQ:KYMR   4:00:00 PM EDT
44.53
+0.09 (+0.20%)
: $45.02 +0.49 (+1.10%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)3.13B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$21.11 Million
Adjusted EPS-$0.80
See more estimates
10-Day MA$44.94
50-Day MA$37.99
200-Day MA$39.43
See more pivots

Kymera Therapeutics Inc Stock, NASDAQ:KYMR

500 North Beacon Street, 4th floor, Watertown, Massachusetts 02472
United States of America
Phone: +1.857.285.5300
Number of Employees: 188

Description

Kymera Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and development of small molecule therapeutics that degrade disease-causing proteins. The company was founded by Bruce Lee Booth and Nello Mainolfi in September 2015 and is headquartered in Watertown, MA.